Reverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric Population

Journal of the American Medical Directors Association

Volumn 16, Issue 11, 2015, Pages 933-939

  Ahmadi, Seyed Foad ^a,b   Streja, Elani ^a,c   Zahmatkesh, Golara ^a   Streja, Dan ^d   Kashyap, Moti ^c   Moradi, Hamid ^a   Molnar, Miklos Z ^e   Reddy, Uttam ^a   Amin, Alpesh N ^g   Kovesdy, Csaba P ^e,f   Kalantar Zadeh, Kamyar ^a,b,c,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^d Providence Medical Institute   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular risk factors; Mortality; Obesity paradox; Reverse epidemiology; Risk factor paradox

Indexed keywords

ADIPOCYTOKINE; CHOLESTEROL; ENDOTOXIN; LIPOPROTEIN; TOXIN; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADIPOSE TISSUE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; DIALYSIS; END STAGE RENAL DISEASE; EPIDEMIOLOGICAL DATA; GERIATRICS; HEART FAILURE; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; OBESITY; PATHOPHYSIOLOGY; REVIEW; RHEUMATOID ARTHRITIS; AGED; CARDIOVASCULAR DISEASES; COMPLICATION; MIDDLE AGED; MORTALITY; RISK FACTOR; UNITED STATES;

AGED; CARDIOVASCULAR DISEASES; HUMANS; HYPERCHOLESTEROLEMIA; MIDDLE AGED; OBESITY; RISK FACTORS; UNITED STATES;

EID: 84947862750     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.07.014     Document Type: Review

References (58)

1. US Administration on Aging. US population totals by age group and sex in the 2010 and 2000 Censuses. Available at: Accessed April 27, 2015. http://www.aoa.acl.gov/Aging_Statistics/Census_Population/census2010/Index.aspx.
2. US Administration on Aging. Projected future growth of the older population: 1900 to 2050. Available at: Accessed April 27, 2015. http://www.aoa.acl.gov/aging_statistics/future_growth/future_growth.aspx.
3. Arnold A.M., Psaty B.M., Kuller L.H., et al. Incidence of cardiovascular disease in older Americans: The Cardiovascular Health Study. J Am Geriatr Soc 2005, 53:211-218.
4. Peter R.S., Mayer B., Concin H., Nagel G. The effect of age on the shape of the BMI-mortality relation and BMI associated with minimum all-cause mortality in a large Austrian cohort. Int J Obes (Lond) 2015, 39:530-534.
5. Al Snih S., Ottenbacher K.J., Markides K.S., et al. The effect of obesity on disability vs mortality in older Americans. Arch Intern Med 2007, 167:774-780.
6. Winter J.E., MacInnis R.J., Wattanapenpaiboon N., Nowson C.A. BMI and all-cause mortality in older adults: A meta-analysis. Am J Clin Nutr 2014, 99:875-890.
7. Newson R.S., Felix J.F., Heeringa J., et al. Association between serum cholesterol and noncardiovascular mortality in older age. J Am Geriatr Soc 2011, 59:1779-1785.
8. Akerblom J.L., Costa R., Luchsinger J.A., et al. Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders. Age Ageing 2008, 37:207-213.
9. Tuikkala P., Hartikainen S., Korhonen M.J., et al. Serum total cholesterol levels and all-cause mortality in a home-dwelling elderly population: A six-year follow-up. Scand J Prim Health Care 2010, 28:121-127.
10. Volpato S., Leveille S.G., Corti M.C., et al. The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc 2001, 49:1142-1147.
11. Oates D.J., Berlowitz D.R., Glickman M.E., et al. Blood pressure and survival in the oldest old. J Am Geriatr Soc 2007, 55:383-388.
12. Gutiérrez-Misis A., Sánchez-Santos M.T., Banegas J.R., et al. Association between blood pressure and mortality in a Spanish cohort of persons aged 65 years or over: A dynamic model. Rev Esp Cardiol (Engl Ed) 2013, 66:464-471.
13. Kalantar-Zadeh K., Horwich T.B., Oreopoulos A., et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 2007, 10:433-442.
14. Kalantar-Zadeh K., Rhee C.M., Amin A.N. To legitimize the contentious obesity paradox. Mayo Clin Proc 2014, 89:1033-1035.
15. Park J., Ahmadi S.-F., Streja E., et al. Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis 2014, 56:415-425.
16. Manson J.E., Willett W.C., Stampfer M.J., et al. Body weight and mortality among women. N Engl J Med 1995, 333:677-685.
17. Calle E.E., Thun M.J., Petrelli J.M., et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999, 341:1097-1105.
18. Berrington de Gonzalez A., Hartge P., Cerhan J.R., et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010, 363:2211-2219.
19. Whitlock G., Lewington S., Sherliker P., et al. Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083-1096. Prospective Studies Collaboration.
20. Wang Z. Age-dependent decline of association between obesity and mortality: A systematic review and meta-analysis. Obes Res Clin Pract 2015, 9:1-11.
21. Zajacova A., Burgard S.A. Shape of the BMI-mortality association by cause of death, using generalized additive models: NHIS 1986-2006. J Aging Health 2012, 24:191-211.
22. Holme I., Tonstad S. Survival in elderly men in relation to midlife and current BMI. Age Ageing 2015, 44:434-439.
23. Bales C.W., Buhr G. Is obesity bad for older persons? A systematic review of the pros and cons of weight reduction in later life. J Am Med Dir Assoc 2008, 9:302-312.
24. Batsis J.A., Singh S., Lopez-Jimenez F. Anthropometric measurements and survival in older Americans: Results from the Third National Health and Nutrition Examination Survey. J Nutr Health Aging 2014, 18:123-130.
25. Rolland Y., Gallini A., Cristini C., et al. Body-composition predictors of mortality in women aged ≥ 75 y: Data from a large population-based cohort study with a 17-y follow-up. Am J Clin Nutr 2014, 100:1352-1360.
26. de Hollander E.L., Bemelmans W.J., Boshuizen H.C., et al. The association between waist circumference and risk of mortality considering body mass index in 65- to 74-year-olds: A meta-analysis of 29 cohorts involving more than 58 000 elderly persons. Int J Epidemiol 2012, 41:805-817.
27. Lee C.G., Boyko E.J., Nielson C.M., et al. Mortality risk in older men associated with changes in weight, lean mass, and fat mass. J Am Geriatr Soc 2011, 59:233-240.
28. LeFevre M.L. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2014, 161:587-593. US Protective Services Task Force.
29. Klag M.J., Ford D.E., Mead L.A., et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 1993, 328:313-318.
30. Tikhonoff V., Casiglia E., Mazza A., et al. Low-density lipoprotein cholesterol and mortality in older people. J Am Geriatr Soc 2005, 53:2159-2164.
31. Krumholz H.M., Seeman T.E., Merrill S.S., et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA 1994, 272:1335-1340.
32. Corti M.C., Guralnik J.M., Salive M.E., et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 1997, 126:753-760.
33. Petersen L.K., Christensen K., Kragstrup J. Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing 2010, 39:674-680.
34. Ridker P.M., Danielson E., Fonseca F.A., et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial. Lancet 2009, 373:1175-1182.
35. Glynn R.J., Koenig W., Nordestgaard B.G., et al. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: Exploratory analysis of a randomized trial. Ann Intern Med 2010, 152:488-496. W174.
36. Savarese G., Gotto A.M., Paolillo S., et al. Benefits of statins in elderly subjects without established cardiovascular disease: A meta-analysis. J Am Coll Cardiol 2013, 62:2090-2099.
37. Stone N.J., Robinson J., Lichtenstein A.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation 2013, 129:S1-S72.
38. Vasan R.S., Larson M.G., Leip E.P., et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001, 345:1291-1297.
39. Lewington S., Clarke R., Qizilbash N., et al. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
40. Mørkedal B., Romundstad P.R., Vatten L.J. Mortality from ischaemic heart disease: Age-specific effects of blood pressure stratified by body-mass index: The HUNT cohort study in Norway. J Epidemiol Community Health 2011, 65:814-819.
41. Bejan-Angoulvant T., Saadatian-Elahi M., Wright J.M., et al. Treatment of hypertension in patients 80 years and older: The lower the better? A meta-analysis of randomized controlled trials. J Hypertens 2010, 28:1366-1372.
42. Schall P., Wehling M. Treatment of arterial hypertension in the very elderly: A meta-analysis of clinical trials. Arzneimittelforschung 2011, 61:221-228.
43. James P.A., Oparil S., Carter B.L., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014, 311:507-520.
44. Kalantar-Zadeh K., Block G., Humphreys M.H., Kopple J.D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003, 63:793-808.
45. Kalantar-Zadeh K., Block G., Horwich T., Fonarow G.C. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004, 43:1439-1444.
46. Horwich T.B., Fonarow G.C., Hamilton M.A., et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001, 38:789-795.
47. Kuwano K., Hara N. Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family. Am J Respir Cell Mol Biol 2000, 22:147-149.
48. Strieter R.M., Kunkel S.L., Bone R.C. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med 1993, 21:S447-S463.
49. Stenvinkel P., Marchlewska A., Pecoits-Filho R., et al. Adiponectin in renal disease: Relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004, 65:274-281.
50. Mohamed-Ali V., Goodrick S., Bulmer K., et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999, 277:E971-E975.
51. Lundin J.I., Checkoway H. Endotoxin and cancer. Environ Health Perspect 2009, 117:1344-1350.
52. Morris M.C., Gilliam E.A., Li L. Innate immune programing by endotoxin and its pathological consequences. Front Immunol 2014, 5:680.
53. Rauchhaus M., Coats A.J., Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet 2000, 356:930-933.
54. Jandacek R.J., Anderson N., Liu M., et al. Effects of yo-yo diet, caloric restriction, and olestra on tissue distribution of hexachlorobenzene. Am J Physiol Gastrointest Liver Physiol 2005, 288:G292-G299.
55. Kalantar-Zadeh K., Kopple J.D. Obesity paradox in patients on maintenance dialysis. Contrib Nephrol 2006, 151:57-69.
56. Macleod J., Davey Smith G. Psychosocial factors and public health: A suitable case for treatment?. J Epidemiol Community Health 2003, 57:565-570.
57. Kalantar-Zadeh K., Abbott K.C., Kronenberg F., et al. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol 2006, 26:118-133.
58. Ahmadi S.-F., Zahmatkesh G., Streja E., et al. Body mass index and mortality in kidney transplant recipients: A systematic review and meta-analysis. Am J Nephrol 2014, 40:315-324.